These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 577181)

  • 41. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.
    Stanaszek WF; Kellerman D; Brogden RN; Romankiewicz JA
    Drugs; 1983 Apr; 25(4):339-84. PubMed ID: 6303744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemodynamic changes caused by prazocin in patients with uncomplicated arterial hypertension].
    Ban Hayashi E; Meaney E; Rivera JM
    Arch Inst Cardiol Mex; 1983; 53(4):357-62. PubMed ID: 6639214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antihypertensive action of drug combination: polythiazide, prazosin and tolamolol.
    Pitkäjärvi T; Kyöstilä S; Kontro J
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):169-76. PubMed ID: 403051
    [No Abstract]   [Full Text] [Related]  

  • 44. Hemodynamic adjustments in hypertensive patients developing circulatory congestion during beta-adrenergic blockade.
    Reybrouck T; Amery A; Billiet L; Fagard R
    Cardiology; 1979; 64(2):97-109. PubMed ID: 436128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of atenolol or prazosin on maximal exercise performance in hypertensive joggers.
    Thompson PD; Cullinane EM; Nugent AM; Sady MA; Sady SP
    Am J Med; 1989 Jan; 86(1B):104-9. PubMed ID: 2913765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study of the use of prazosin in hypertensive patients in Korea.
    Kim JS
    Clin Sci Mol Med Suppl; 1976 Dec; 3():613s-616s. PubMed ID: 1071691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Changes in blood viscosity concomitant with prazosin therapy in patients with essential arterial hypertension].
    Letcher RL; Chien S; Laragh JG
    Cardiology; 1980; 66 Suppl 2():12-25. PubMed ID: 6269739
    [No Abstract]   [Full Text] [Related]  

  • 48. Physiologic effects of prazosin HCl: consequences of diuretic combination therapy.
    Blaufox MD; Ross L; Koshy K; Lee HB
    Nephron; 1981; 29(1-2):85-9. PubMed ID: 7329480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative effects of prazosin and phenoxybenzamine on arterial blood pressure, heart rate, and plasma catecholamines in essential hypertension.
    Mulvihill-Wilson J; Graham RM; Pettinger W; Muckleroy C; Anderson S; Gaffney FA; Blomqvist CG
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S1-7. PubMed ID: 94635
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of prazosin and oxprenolol on plasma renin activity and blood pressure in patients with essential hypertension.
    Farsang C; Juhász I; Kapocsi J; Vajda L; Székács B
    Cardiology; 1981; 67(3):164-71. PubMed ID: 7023672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic and regional haemodynamic effects of vasodilators in hypertension.
    Struyker-Boudier HA; Smits JF
    Neth J Med; 1984; 27(4):146-52. PubMed ID: 6330588
    [No Abstract]   [Full Text] [Related]  

  • 52. Congestive cardiomyopathy: therapeutic approach.
    Chatterjee K; Stern L
    Compr Ther; 1982 Jul; 8(7):25-34. PubMed ID: 7116806
    [No Abstract]   [Full Text] [Related]  

  • 53. [Changes in renal arterial flow during the treatment of essential arterial hypertension; prazosin in comparison with propranolol].
    O'Connor DT; Preston RA; Sasso EH
    Cardiology; 1980; 66 Suppl 2():69-73. PubMed ID: 7285032
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparative effects of tolamolol and propranolol on cardiac and peripheral circulatory function in patients with coronary artery disease.
    Miller RR; Vismara LA; Mason DT
    Clin Pharmacol Ther; 1975 Jun; 17(6):713-21. PubMed ID: 1095282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Sustained and beneficial hemodynamic effects of prazosin in cardiac insufficiency].
    Harrison DC; Feldman RC; Ball RM
    Cardiology; 1980; 66 Suppl 2():162-8. PubMed ID: 6456814
    [No Abstract]   [Full Text] [Related]  

  • 56. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hemodynamic effect of a combination of prazosin with cardiac depressants in the treatment of hypertension].
    Moiseev VS; Ivleva AIa; Akopian LM; Krasnobaeva GM; Basem AS
    Kardiologiia; 1988 Jan; 28(1):20-4. PubMed ID: 2965770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prazosin-induced haemodynamic modification in human hypertension. Evidence from strain-gauge plethysmography. Part II.
    Romano S; Gizdulich P; Scarpelli PT
    Methods Find Exp Clin Pharmacol; 1981; 3(1):13-5. PubMed ID: 7230971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hemodynamic effects of bunitrolol].
    Dabizzi RP; Padeletti L; Bechi P
    Boll Soc Ital Cardiol; 1977; 22(2):139-42. PubMed ID: 36113
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of prazosin on platelet aggregation and plasma beta-thromboglobulin in essential hypertension.
    Ikeda T; Nonaka Y; Goto A; Ishii M
    Clin Pharmacol Ther; 1985 Jun; 37(6):601-5. PubMed ID: 2408807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.